|
1 |
16 01 2026 |
Delhi and Pondicherry join nationwide crackdown on toxic Almont-Kid paediatric syrup |
Pharmabiz |
India |
|
2 |
16 01 2026 |
Venus Remedies secures Marketing Authorisation for Ceftazidime , Avibactam FDC in Indonesia |
Medical Dialogues |
India |
|
3 |
16 01 2026 |
USFDA,EMA issue First Joint Guidelines on safe use of AI in Drug development. |
Medical Dialogues |
India |
|
4 |
16 01 2026 |
Indian Pharma Q3 Outlook: Domestic Formulations to Counter US Pricing Pressure |
Scanx Trade |
India |
|
5 |
16 01 2026 |
USA oversight of Venezuelan oil may unlock Indian Pharma dues ,revive exports |
Money Control |
Venezuela |
|
6 |
16 01 2026 |
Fake Levipil 500 Tablets posing as Sun Pharma product seized in Telangana. |
Medical Dialogues |
India |
|
7 |
15 01 2026 |
Pharma, biotech sectors ask govt to restore weighted R&D incentives to save India’s innovation edge |
Pharmabiz |
India |
|
8 |
15 01 2026 |
GLP-1 innovation & chronic care surge propel Indian pharma to a record Rs. 2.4 lakh crore valuation |
Pharmabiz |
India |
|
9 |
15 01 2026 |
Fake ISO certificates claiming safety and quality of medical devices need to be verified: Experts |
Pharmabiz |
India |
|
10 |
14 01 2026 |
Vadodara Researcher's innovation: Freeze Dried Technology that improves Longevity of Cancer drugs |
Medical Dialogues |
India |
|
11 |
14 01 2026 |
Centre Review GTE exemtion for 11 Specialty drugs, Domestic Pharma asked to raise objections. |
Medical Dialogues |
India |
|
12 |
14 01 2026 |
Ajanta Pharma sets up Wholly owned subsidiary in Ireland |
Medical Dialogues |
India |
|
13 |
14 01 2026 |
DGFT revamps eBRC framework with GST details made mandatory from January 13, 2026 |
Pharmabiz |
India |
|
14 |
14 01 2026 |
Karnal emerges as potential pharma hub, HPMA demands strategic support for MSMEs |
Pharmabiz |
India |
|
15 |
14 01 2026 |
Life sciences industry seeks dedicated cybersecurity funds, PLI policy continuity in Union Budget 2026 |
Pharmabiz |
India |
|
16 |
14 01 2026 |
Jharkhand DCA demands formal correction from CDL Kolkata to cough syrup test report |
Pharmabiz |
India |
|
17 |
14 01 2026 |
IPA-CPD urges health ministry to amend rules to mandate red line on labels of antibiotics |
Pharmabiz |
India |
|
18 |
14 01 2026 |
India pharma turns to specialty drugs as generics pricing bite deepens |
Business Today |
India |
|
19 |
14 01 2026 |
Dr. Reddy’s launches first generic equivalent of extra-strength Pataday in US |
India Pharma Post |
India |
|
20 |
13 01 2026 |
DoP may exempt 11 more drugs from public procurement rules that restricts global tender |
Pharmabiz |
India |
